WallStreetZenWallStreetZen

NASDAQ: MLTX
Moonlake Immunotherapeutics Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for MLTX

Based on 8 analysts offering 12 month price targets for Moonlake Immunotherapeutics.
Min Forecast
$59.00+6.5%
Avg Forecast
$75.38+36.06%
Max Forecast
$92.00+66.06%

Should I buy or sell MLTX stock?

Based on 8 analysts offering ratings for Moonlake Immunotherapeutics.
Strong Buy
Strong Buy
4 analysts 50%
Buy
3 analysts 37.5%
Hold
1 analysts 12.5%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their MLTX stock forecasts and price targets.

MLTX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2023-12-08
lockedlocked$00.00+00.00%2023-12-01
lockedlocked$00.00+00.00%2023-11-27
lockedlocked$00.00+00.00%2023-11-15
lockedlocked$00.00+00.00%2023-11-08
Stifel Nicolaus
Top 16%
85
Strong BuyInitiates Coverage On$74.00+33.57%2023-11-02
Needham
Bottom 1%
1
BuyReiterates$76.00+37.18%2023-10-16
Barclays
Top 24%
77
HoldMaintains$59.00+6.50%2023-09-12

1 of 1

Forecast return on equity

Is MLTX forecast to generate an efficient return?
Company
-26.3%
Industry
28.84%
Market
39.07%
MLTX's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is MLTX forecast to generate an efficient return on assets?
Company
-22.35%
Industry
10.9%
MLTX is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

MLTX revenue forecast

What is MLTX's revenue in the next 3 years based on estimates from 3 analysts?
Avg 1 year Forecast
$90.4M
Avg 2 year Forecast
$554.9M
Avg 3 year Forecast
$1.3B

MLTX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
MLTX$55.40$75.38+36.06%Strong Buy
ACAD$20.98$33.33+58.88%Buy
CYTK$34.10$61.00+78.89%Strong Buy
RARE$40.46$96.40+138.26%Strong Buy
AXSM$70.18$108.43+54.50%Strong Buy
View Top Biotech Stocks

Moonlake Immunotherapeutics Stock Forecast FAQ

Is Moonlake Immunotherapeutics Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 8 Wall Street analysts covering (NASDAQ: MLTX) stock is to Strong Buy MLTX stock.

Out of 8 analysts, 4 (50%) are recommending MLTX as a Strong Buy, 3 (37.5%) are recommending MLTX as a Buy, 1 (12.5%) are recommending MLTX as a Hold, 0 (0%) are recommending MLTX as a Sell, and 0 (0%) are recommending MLTX as a Strong Sell.

If you're new to stock investing, here's how to buy Moonlake Immunotherapeutics stock.

What is MLTX's revenue growth forecast for 2027-2029?

(NASDAQ: MLTX) Moonlake Immunotherapeutics's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 63.49%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 6.64%.

Moonlake Immunotherapeutics's revenue in 2023 is $0.On average, 3 Wall Street analysts forecast MLTX's revenue for 2027 to be $5,644,494,392, with the lowest MLTX revenue forecast at $5,133,061,611, and the highest MLTX revenue forecast at $6,024,166,102. On average, 3 Wall Street analysts forecast MLTX's revenue for 2028 to be $34,649,414,794, with the lowest MLTX revenue forecast at $17,266,320,383, and the highest MLTX revenue forecast at $44,405,354,156.

In 2029, MLTX is forecast to generate $84,000,492,546 in revenue, with the lowest revenue forecast at $37,417,646,196 and the highest revenue forecast at $121,014,737,550.

What is MLTX's forecast return on assets (ROA) for 2023-2025?

(NASDAQ: MLTX) forecast ROA is -22.35%, which is lower than the forecast US Biotechnology industry average of 10.9%.

What is MLTX's Price Target?

According to 8 Wall Street analysts that have issued a 1 year MLTX price target, the average MLTX price target is $75.38, with the highest MLTX stock price forecast at $92.00 and the lowest MLTX stock price forecast at $59.00.

On average, Wall Street analysts predict that Moonlake Immunotherapeutics's share price could reach $75.38 by Dec 8, 2024. The average Moonlake Immunotherapeutics stock price prediction forecasts a potential upside of 36.06% from the current MLTX share price of $55.40.

What is MLTX's forecast return on equity (ROE) for 2023-2025?

(NASDAQ: MLTX) forecast ROE is -26.3%, which is considered weak.
©2023 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.